局部晚期鼻咽癌治疗研究进展  

Research progress in treatment of locally advanced nasopharyngeal carcinoma

作　　者：朱映霞[1] 李苗 梁家义[1] ZHU Yingxia;LI Miao;LIANG Jiayi(Department of Internal Medicine-Oncology,The First People’s Hospital of Qinzhou,Qinzhou,Guangxi 535000,China)

机构地区：[1]钦州市第一人民医院肿瘤科,广西钦州535000

出　　处：《医药前沿》2023年第2期30-33,共4页Journal of Frontiers of Medicine

基　　金：广西壮族自治区卫生健康委员会自筹经费科研课题(Z-N20221893)。

摘　　要：鼻咽癌是我国华南地区高发癌种之一,且多数患者在诊断时多为局部晚期,5年总生存率亦随之下降,因此对于局部晚期鼻咽癌患者的治疗成为治疗重点。在精准治疗时代,放疗技术的不断进步,以同步放化疗为主,辅以靶向、免疫等治疗成为研究热点。本文就局部晚期鼻咽癌治疗中的现状及热点问题进行综述。Nasopharyngeal carcinoma(NPC)is one of the most common cancers in South China,and most patients are diagnosed as locally advanced,and the 5-year overall survival rate also decreases.Therefore,the treatment of local NPC patients has become the focus of treatment.In the era of precision medicine,with the continuous progress of radiotherapy technology,concurrent chemoradiotherapy,supplemented by targeted therapy and immunotherapy,has become a research hotspot.This article reviews the current status and hot issues in the treatment of locally advanced nasopharyngeal carcinoma.

关 键 词：综述 鼻咽癌 放疗 化疗 靶向治疗 免疫治疗 

分 类 号：R739.63[医药卫生—肿瘤]